Home
/
CITIUS ONCOLOGY, INC.
/
Financials
/
Quarterly
CITIUS ONCOLOGY, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CITIUS ONCOLOGY, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 31, 2025
$3.94M
Feb 13, 2026
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 31, 2025
($5.53M)
Feb 13, 2026
Q3
2025
Jun 30, 2025
($5.37M)
Aug 12, 2025
Q3
2025
Mar 31, 2025
($7.74M)
Aug 12, 2025
Q2
2025
Mar 31, 2025
($7.74M)
May 14, 2025
Q1
2026
Dec 31, 2024
($6.66M)
Feb 13, 2026
Q2
2025
Dec 31, 2024
($6.66M)
May 14, 2025
Q3
2025
Dec 31, 2024
($6.66M)
Aug 12, 2025
Q2
2024
Jun 30, 2024
$252.5K
Aug 9, 2024
Q3
2025
Jun 30, 2024
($4.77M)
Aug 12, 2025
Q1
2024
Mar 31, 2024
$489.8K
May 20, 2024
Q3
2025
Mar 31, 2024
($4.84M)
Aug 12, 2025
Q2
2025
Mar 31, 2024
($4.84M)
May 14, 2025
Q2
2025
Dec 31, 2023
($4.73M)
May 14, 2025
Q1
2025
Dec 31, 2023
($4.73M)
Feb 14, 2025
Q3
2025
Dec 31, 2023
($4.73M)
Aug 12, 2025
Q3
2023
Sep 30, 2023
$157.9K
Nov 20, 2023
Q3
2023
Jun 30, 2023
$616.3K
Nov 20, 2023
Q2
2024
Jun 30, 2023
$616.3K
Aug 9, 2024
Q3
2023
Mar 31, 2023
$611.7K
Nov 20, 2023
Q2
2024
Mar 31, 2023
$611.7K
Aug 9, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 31, 2025
($5.25M)
Feb 13, 2026
Q3
2025
Jun 30, 2025
($4.94M)
Aug 12, 2025
Q1
2026
Dec 31, 2024
($6.39M)
Feb 13, 2026
Q3
2025
Jun 30, 2024
($4.63M)
Aug 12, 2025
Q2
2024
Jun 30, 2024
($384.0K)
Aug 9, 2024
Q1
2024
Mar 31, 2024
($268.4K)
May 20, 2024
Q3
2023
Sep 30, 2023
($421.5K)
Nov 20, 2023
Q2
2024
Jun 30, 2023
($199.6K)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($147.9K)
May 20, 2024